Invest
   Home   |   Business News   |   Personal Finance   |   World News   |   U.S. News   |   Technology   |   Stock Alert   |   Stock Picks  |   Breaking News  |   Forex  |   Gold
Custom Search

Resmed Inc. (RMD) Has Soared To A New High On Strong Q2 Earnings

Resmed Inc. (RMD) reported second quarter EPS of $1.00 after the close Monday, up from $0.73 in the previous year. Street expectations were for EPS of $0.78.

Netflix Inc. (NFLX) Has Surged To A New High On Q4 Results

Netflix Inc. (NFLX) reported fourth quarter EPS of $0.41 after the bell Monday, up from $0.15 a year ago. The result was in line with analysts' expectations. Revenues rose 32.7% to $3.29 billion from $2.48 billion last year.

Halliburton Co. (HAL) Is Up Sharply After Q4 Report

Halliburton Co. (HAL) reported fourth quarter adjusted income from continuing operations of $0.53 Monday morning, compared to $0.04 last year. The consensus estimate was for EPS of $0.46.

Wynn Resorts Ltd. (WYNN) Has Risen To A New High After Q4 Profit Beat

Wynn Resorts Ltd. (WYNN) reported fourth quarter EPS of $1.40 Monday morning, up from $0.50 in the prior year period. Analysts expected EPS of $1.38.

Wyndham Worldwide (WYN) Has Surged To A New High After Acquisition

Wyndham Worldwide (WYN) announced Thursday morning that it has agreed to acquire La Quinta's hotel franchise and hotel management businesses for $1.95 billion in cash.

M&T Bank Corp. (MTB) Has Risen To A New High On Strong Q4 Results

M&T Bank Corp. (MTB) reported fourth quarter EPS of $2.01 Thursday morning, up from $1.98 in the prior year period. Street expectations were for EPS of $2.40.

Juno Therapeutics (JUNO) Has Jumped To A New High On Reports Of Merger Talks

The Wall Street Journal reported Tuesday that Celgene (CELG) is in talks to acquire Juno Therapeutics Inc. (JUNO).

Merck & Co. Inc. (MRK) Is Up Sharply On Phase 3 Study Results

Merck & Co. Inc. (MRK) announced Tuesday morning that its Phase 3 trial of KEYTRUDA in combination with pemetrexed and cisplatin or carboplatin, for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, met its dual primary endpoints of overall survival and progression-free survival.
 
 
   DOW JONES
  
   NASDAQ
 
   S & P 500



 

  

 



 
 
 
   Latest News From CNN Money

Americans are warming up to self-driving cars
AT&T wants Congress to pass a net neutrality law
$30 million race to moon ends without a winner
Trump tariffs could threaten thousands of jobs
GE's 'black box' mystery spooks Wall Street
 
 
   Latest News From The Wall Street Journal
Clash Between Founder and Protégé Plunges Och-Ziff Into Crisis
 
  Home
  Business News
  Personal Finance
  World News
  U.S. News
  Technology

         

               
                 Copyright ©, Invest.